Journal article

Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody

Edward B Reilly, Andrew C Phillips, Fritz G Buchanan, Gillian Kingsbury, Yumin Zhang, Jonathan A Meulbroek, Todd B Cole, Peter J DeVries, Hugh D Falls, Christine Beam, Jinming Gu, Enrico L Digiammarino, Joann P Palma, Cherrie K Donawho, Neal C Goodwin, Andrew M Scott

Molecular Cancer Therapeutics | AMER ASSOC CANCER RESEARCH | Published : 2015

University of Melbourne Researchers


Funding Acknowledgements

N.C. Goodwin is the Vice President of Champions Oncology, Inc. A.M. Scott reports receiving commercial research support from AbbVie and has ownership interest (including patents) in the Ludwig Institute for Cancer Research. No potential conflicts of interest were disclosed by the other authors.